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 PRL is not only elevated post-partum, but is elevated by 
other factors too. Besides a sex diff erence-PRL levels are roughly 
one-third higher in women than in men (New et  al. 2004)- 
factors such as pregnancy, primary hyperthyroidism, medications, 
tumour of the pituitary, stress, anxiety and pain are all related to 
increased PRL levels (Mah and Webster 2002). Up to 10% of the 
population may have PRL levels above the normal range (Josimo-
vich et  al. 1987). Furthermore, PRL serves multiple functions in 
the body other than lactation. For example, PRL impacts immune 
function, reproductive behaviour, sleep and the stress response 
(Freeman et  al. 2000). 
 Some research has found that PRL is associated with 
aggression in animals (Numan 1988) and hostility in humans 
(Fava et  al. 1981; Fava et  al. 1988; Mastrogiacomo et  al. 1982; 
Kellner et  al. 1984). It has been suggested that underlying this 
association is an adaptive mechanism called  ‘ maternal aggres-
sion ’ ; the high levels of PRL normally seen in female mammals 
shortly aft er giving birth promote behaviour in the mother that is 
protective of the newborn (Numan 1988). 
 Medical conditions and medication 
 PRL is a pituitary hormone, and hyperprolactinaemia  – serum 
levels above 500 mIU/L  – is the most common endocrine disor-
der of the hypothalamic – pituitary axis (Mah and Webster 2002). 
Pituitary tumour, a micro-adenoma that secretes PRL, is the 
most common cause of hyperprolactinaemia once other causes 
(pregnancy, primary hypothyroidism and drugs) are excluded 
(Mah and Webster 2002). PRL negatively regulates pituitary 
hormones implicated in gonadal function, thus hyperprolacti-
naemia is oft en associated with menstrual and fertility problems 
(Serri et  al. 2003). As dopamine is a major PRL inhibitory factor, 
medications that impact the hypothalamic dopamine system or 
pituitary dopamine receptors aff ect PRL levels (Mah and Webster 
2002). For example, tricyclic anti-depressants, opiates and other 
medications that aff ect central dopamine transmission in turn 
increase PRL levels (Mah and Webster 2002; Torre and Falorni 
2007). Some other medications are said to increase PRL level, for 
example, oral contraceptives (Torre and Falorni 2007) or second-
generation anti-psychotics (Penzner et  al. 2009), but the eff ects of 
these medications on PRL levels may be weak. 
 Life stress, anxiety and pain 
 Patients with hyperprolactinaemia have been found to report 
signifi cantly higher life event scores, when controlling for age, 
sex, marital status and social class (Sonino et  al. 2004). 
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 The aim of this systematic review and meta-analysis was 
to assess any diff erence in the self-ratings of hostility in 
mentally healthy women with diff erent levels of prolactin 
(PRL). Electronic databases (PubMed, MEDLINE, EMBASE and 
the Cochrane Library) were searched up to 2nd July 2012 for 
published literature comparing hostility levels in women with 
diff erent levels of PRL. Keyword pairs ( ‘ prolactin ’ and  ‘ aggression ’, 
 ‘ prolactin ’ and  ‘ hostil * ’,  ‘ prolactin ’ and  ‘ anger ’, and  ‘ prolactin ’ and 
 ‘ angry ’ ) were entered simultaneously. From 1065 resulting titles, 
and one unpublished study, 214 articles underwent full-text 
review by authors JB and EM. Studies were selected based on 
clinical relevance. Eight comparative studies consisting of 242 
female patients with high PRL levels, 207 female patients with 
normal PRL levels and 127 healthy controls with normal PRL lev-
els were included. Data were analysed using the inverse variance 
method with a random-eff ects model. Analysis revealed signifi -
cantly higher hostility in patients with high PRL compared with 
that in healthy control women ( Z    1.94,  p    0.05; Hedges ’ g    
0.72; 95% confi dence interval [CI]:   0.01 – 1.45), signifi cantly 
higher hostility in patient controls compared with that in healthy 
controls ( Z    1.94,  p    0.05; Hedges ’ g    0.47; 95% CI: 0.00 – 0.94) 
and non-signifi cantly higher hostility levels in patients with 
high PRL compared with that in patients with normal PRL levels 
( Z    1.45,  p    0.15; Hedges ’ g    0.38; 95% CI:   0.13 – 0.89). In 
this meta-analysis, hostility appears to be accounted for partly 
by PRL levels and also partly by patient status, perhaps due to 
the stress of being a patient. Methodological considerations and 
implications for patient care are discussed. 
 Keywords:  Hostility ,  meta-analysis ,  prolactin ,  patient care ,  review 
 Prolactin, pregnancy and hostility 
 Prolactin (PRL) receptors are seen mainly in the hypothalamus, 
where binding is especially high in females (Di Carlo et  al. 1992). 
It is well established that the hypothalamus is implicated in the 
control of aggression in humans (Siegel and Victoroff  2009). 
Th erefore it is plausible that PRL could be associated with aggres-
sion, especially in women around the time of birth when PRL 
levels are naturally at their highest (Battin et  al. 1985). However, 
not all studies have found that PRL levels are related to hostility 
or aggression (e.g., Barry et  al. 2014). Th is might be due in part to 
the heterogeneity of participant characteristics across the various 
studies, as discussed below. 
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Furthermore, the onset of symptoms of hyperprolactinaemia may 
coincide with important life events (Nunes et  al. 1980). Th ere is 
evidence that stressful early life events are related to hyperprolac-
tinaemia (Nunes et  al. 1980). However, the exact role of life events 
in the pathogenesis of hyperprolactinaemia remains unknown 
(Sonino et  al. 2004). Th e relationship may be complex; for exam-
ple, although one study found that childhood stress was related 
to hyperprolactinaemia in adulthood, the onset of the condition 
did not coincide with important life events (Assies et  al. 1992). 
 Higher PRL levels have been associated with acute stress among 
healthy populations (Fava and Guaraldi 1987; Biondi and Picardi 
1999). It is also well established that PRL secretion is aff ected 
by stress (Freeman et  al. 2000), and PRL secretion increases in 
response to stress in both animals (Donner et  al. 2007; Torner 
and Neumann 2002; Torner et  al. 2004) and humans (Reavley 
et  al. 1997; Sonino et  al. 2004). Anxiety is known to be related 
to increased PRL levels (Fava et  al. 1981; Fava et  al. 1988; 
Mastrogiacomo et  al. 1982; Kellner et  al. 1984; Reavley et  al. 1997). 
Among women who are seeking medical treatment, high anxiety 
has been related to high levels of PRL (Fava et  al. 1988; Reavley 
et  al. 1997). Additionally, PRL is known to increase in response to 
pain, mediated by several neurological factors, notably dopamine 
levels (Ben-Jonathan and Hnasko 2001; Del Pozo and Brownell 
1979). 
 Animal studies have shown that PRL, released in response to 
stress (Torner et  al. 2004), decreases the stress response across a 
variety of dimensions (Donner et  al. 2007; Torner and Neumann 
2002). PRL impacts the behavioural, neurological and endocrine 
stress responses, for example, by decreasing stress-induced adre-
nocorticotropic hormone release (Donner et  al. 2007; Torner and 
Neumann 2002). 
 Aggression and hostility 
 Research assessing PRL and aggression-related emotions gener-
ally tends to focus on hostility, rather than anger or aggression. 
Although anger, aggression and hostility are all similar negative 
emotional states and may be used interchangeably in everyday 
conversation, these three constructs can be distinguished from 
each another. Miller et  al. (Miller et  al. 1996) defi ne anger as an 
unpleasant emotion which may be experienced cognitively and/
or physiologically; aggression is an overt behaviour, which may 
be expressed verbally or physically; and hostility is a negative 
cognitive state, involving beliefs and attitudes about other people, 
characterised by mistrust, cynicism and suspicion of others. Also, 
a distinction is oft en made between transient states of anger and 
enduring trait of hostility. While state anger is evident at a par-
ticular time, trait hostility is a more enduring characteristic. It 
is also possible that acute levels of state anger may increase PRL 
levels, and the experience of a chronic stressor  – such as an illness 
 – may lead to chronic increases in PRL. High levels of hostility are 
furthermore related to poor physical health, especially coronary 
heart disease (Miller et  al. 1996). In a meta-analysis assessing 
hostility and physical health, Miller and colleagues (Miller et  al. 
1996) found hostility to be an independent risk factor for coro-
nary heart disease. 
 Comparability of assays over time 
 When comparing PRL levels over time, as in the present study 
where PRL samples spanning three decades are compared, it 
should be noted that there have been three separate International 
Reference Preparations (IRPs) between 1978 and 1988, each 
requiring a review of reference ranges for PRL (Schulster et  al. 
1989). Th us, the IRPs have changed from the fi rst review in 1978 
(IRP 75/504), the second in 1986 (IRP 83/562) to the third in 
1988 (IRP 84/500). Th e assignment of unitage to the second and 
third IRPs has been carefully calibrated to ensure that continuity 
from the fi rst IRP would be maintained. Th erefore, the longitudi-
nal application of the reference range over time can be considered 
robust, provided that assay kit manufacturers have appropriately 
recalibrated their assay against the relevant contemporary IRP. 
 Th e stability of an assay over time will also depend on other 
factors such as continuity of antibody, which could reduce com-
parability of observed values across time. However, it would be 
reasonable to compare broad categories of measurement over 
time, for example, if a value is categorised as below the norm in 
the 1980s then it would be reasonable to infer that it would be 
categorised below the norm today. 
 Hypothesis 
 Given the existing evidence on this topic, it was hypothesised that 
published research would fi nd higher hostility ratings in women 
with elevated PRL levels. 
 Methods 
 Sources 
 Th is review followed the Meta-analysis of Observational Studies 
in Epidemiology (MOOSE) guidelines for systematic reviews of 
observational studies (Stroup and Berlin 2000). A protocol for the 
review has been registered in PROSPERO (Centre for Reviews 
and Dissemination registration number: CRD42012002527). 
 Literature search 
 Articles in any language measuring hostility or aggression and 
PRL, which were listed in PubMed and MEDLINE published up 
to 2nd July 2012, and EMBASE from 1980 to 2nd July 2012, were 
identifi ed. Th e Cochrane Review Database was also searched up 
to 2nd July 2012. Th e keyword search term pairs  ‘ prolactin ’ and 
 ‘ aggression ’,  ‘ prolactin ’ and  ‘ hostil ∗ ’,  ‘ prolactin ’ and  ‘ anger ’, and 
 ‘ prolactin ’ and  ‘ angry ’ were entered simultaneously. Th e PubMed 
searches produced 209 articles for aggression, 65 for hostil ∗ , 21 
for anger and 24 for angry. A MEDLINE search from 1946 did 
not fi nd any articles in addition to those cited in PubMed. Th e 
EMBASE searches produced 322 articles for aggression, 80 for 
hostil ∗ , 43 for anger and 5 for angry. Th e  ‘ related article ’ function 
was used to widen the results. Th e Cochrane Review Database did 
not produce any published reviews on PRL and aggression, hostil-
ity or anger. No further articles were produced by a hand search of 
relevant articles referenced in these publications. A study relevant 
to this topic conducted by the present authors (Barry et  al. 2014) 
was included. Qualifi ed librarians assisted when articles were 
diffi  cult to access. 
 Study selection 
 Each article was assessed by EM or JB, and articles that fi tted the 
main criteria (measuring PRL and aggression, hostility or anger) 
were accessed. When it was unclear whether an article met the 
inclusion criteria, an attempt was made to contact the authors. 
For example, the standard deviation (SD) scores for hostility in 
one of the studies (Gro ë r 2005) were not presented in the pub-
lished article, but an email was sent to the lead author who subse-
quently supplied this information. Although some studies did not 
report PRL values, but rather referred to groups as having  ‘ high ’ 
or  ‘ low ’ PRL levels, such studies were included as their exclusion 
would have limited the number of articles included in this review. 
Age was reported in the selected studies, but was not a factor that 
could be controlled for using meta-analysis because the original 
studies did not report outcomes by age group. 
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 Methodological quality was independently assessed by JB and 
EM based on the criteria of the Newcastle – Ottawa Quality Assess-
ment Scale (NOS) for case – control studies (Wells et  al. 2000) 
adapted for observational studies and for the present study. In 
order for the methodological quality to be relevant to the present 
study rather than to a generalised notion of observational studies 
(Stang 2010), several adaptations to the criteria were made. For 
example,  ‘ ascertainment of exposure ’ was changed to  ‘ ascertain-
ment of diagnosis ’, and studies of hospitalised patients that used 
other patients as controls were considered of higher quality than 
those that used healthy women as a control group. Other changes 
to the NOS criteria are listed in Table I. 
 Inclusion and exclusion criteria 
 Studies were included if they had the following features: 
 Participants were mentally healthy women, indicated by the a) 
absence of a psychiatric diagnosis. 
 Participants were grouped based on naturally occurring (rather b) 
than experimentally induced) PRL level, and hostility was the 
dependent (or outcome) variable. 
 Hostility was measured as a quantitative outcome using a c) 
validated questionnaire scale or subscale. 
 Hostility and PRL were reported in units of means and SDs, d) 
or were presented clearly in graphic form (e.g., a line graph 
 Table I. Characteristics of studies of PRL and hostility indicates (a) high PRL group, (b) patient controls and (c) healthy controls. 
Study
Age 
(years) N
Diagnosis/
Characteristics Assay
Variables 
controlled
Time of blood 
sample
Hostility 
measure
Fava et  al. 
(1981)
(a) 27.3 (8.2)
 (b) 21.4 (4.0)
 (c) nr
(a) 10
 (b) 10
 (c) 10
(a) hyperprolactinaemic amenorrhoea
 (b) amenorrhoea, normal PRL
 (c) female hospital employees
RIA (a)  & (b) no meds, 
age, SEC, 
marriage, 
education (a)  & 
(b)  & (c) age, 
SEC
(a)  & (b) (8 am) 
(c) nr
KSQ
Mastrogiacomo 
et  al. (1982)
(a) nr ∗ 
 (b) nr
 (c) nr
 ∗ same as Fava 81
(a) 10
 (b) 10
 (c) 10
(a) hyperprolactinaemic amenorrhoea
 (b) post-partum controls
 (c) female hospital employees
RIA (a)  & (b)  & (c) 
SEC a 
(a)  & (b) (8 am) 
(c) nr
KSQ
Kellner et  al. 
(1984)
(a) 27.5 (3.6)
 (b) 35.0 (13.7)
 (c) 35.2 (13.2)
(a) 14
 (b) 29
 (c) 26
(a) hyperprolactinaemia
 (b) family practice patients
 (c) non-patient female employees
nr (a)  & (b) age, SEC, 
 & (c) age
(a) (7 – 9 am) (b) 
 & (c) nr
KSQ
Fava et  al. 
(1988)
(a) 51.1 (13.7)
 (b) 47.3 (12.1)
 (c) nr
(a) 10
 (b) 9
 (c) 10
(a) uraemic, hyperprolactinaemia
 (b) uraemic, normoprolactinaemic
 (c) female hospital employees
RIA (a)  & (b) age, SEC, 
marriage,  & (c) 
age
(a)  & (b) (8 am) 
(c) nr
KSQ
Uvn ä s -Moberg 
et  al. (1990)
(a) 27(3.5)
 (c) nr
(a) 50
 (c) 66
(a) 4-day post-partum
 (c) nr
RIA (a)  & (b) age. (a) (10 am) 
 (c) nr
KSP
Reavely et  al. 
(1997)
(a) 38.6
 (b) 53.7
(a) 65
 (b)26
(a) hyperprolactinaemia
 (b) normoprolactinaemic pituitary 
 disease
nr n/a (a)  & (b) nr SCL-90
Gro ë r (2005) (a) 28.9
 (b) 23.4
 (c) 23.8
(a) 84
 (b) 99
 (c) 33
(a) breast-feeding
 (b) bottle feeding
 (c) healthy, non-post-partum 
 non-patient female student nurses
ELISA n/a (a) (8 – 11 am) (b) 
 & (c) nr
POMS
Barry et  al. 
(2014)
(a) 30.03(5.49)
 (b) 29.85 (5.88)
(a)  & (b) 33 (a)  & (b) moderately subfertile, mostly 
PCOS
ECLIA (a)  & (b) no meds, 
age, SEC, anx, 
stress, ethnicity
nr AQ
 RIA: radioimmunoassay. 
 ELISA: enzyme-linked immunosorbent assay. 
 ECLIA: electrochemiluminescence immunoassay. 
 SEC: socioeconomic class. 
 Time of blood sample: time of day in which blood was taken is identiﬁ ed. 
 AQ    Aggression Questionnaire (Hostility subscale). 
 KSQ    Kellner Symptom Questionnaire (Hostility subscale). 
 KSP    Karolinska Scales of Personality (Aggression – Hostility subscale). 
 POMS    Proﬁ le of Mood States (Anger subscale). 
 SCL-90    Symptoms Checklist (Hostility subscale). 
 nr    not reported . 
 a Th is study also matched age, but in decades. 
with error bars, in which means and SDs could be clearly 
identifi ed). 
 Th e studies reported other relevant data, for example, partici-e) 
pant age, numbers of participants per group, etc. 
 Studies were excluded if they 
 Had mixed groups of men and women; a) 
 Participants were children or adolescents — these were excluded b) 
because PRL is known to act diff erently in children than in adults; 
 Data duplicated previously published fi ndings. c) 
 Articles with titles or abstracts that indicated that they were not 
relevant (e.g., reviews, single-case studies, etc.) were excluded. 
 Statistical analysis 
 Statistical analyses were performed using Review Manager, Version 
5.1. Groups of studies were meta-analysed using the inverse variance 
method, with a random-eff ects model, where there was signifi cant 
heterogeneity. Heterogeneity was assessed using I 2 and chi-square 
statistics. An I 2 value of 30% was considered the threshold for mod-
erate heterogeneity, and a chi-square  p value    0.10 was considered 
the threshold for signifi cant heterogeneity. Th us, analyses showing I 2 
values    30% and chi-square  p values    0.10 could be analysed using 
a random-eff ects model, and heterogeneity below the thresholds 
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 Figure 1. Forest plot of women ’ s hostility levels in the seven studies of patients with high levels of PRL compared with patients with normal levels of PRL. 
 Table II. Evaluation of the methodological quality of the eight studies comparing high PRL and patient controls included in the meta-analysis using the 
NOS. Th e study that did not have patient controls, Uvn ä s -Moeberg et  al. (1990), is also assessed. 
Study
Case 
deﬁ nition 
adequate
Representativeness 
of cases
Selection 
of controls
Deﬁ nition 
of controls
Comparability of 
both groups
Ascertainment 
of PRL levels
Same ascertainment 
method for all 
groups
Non-
response 
rate
NOS 
Score
Fava et  al. (1981) X X  ∗  ∗  ∗ (no meds)  ∗  ∗ X 6
Mastrogiacomo et  al. 
(1982)
 ∗  ∗  ∗  ∗ X  ∗  ∗ X 6
Kellner et  al. (1984)  ∗ X  ∗ X X  ∗ X X 3
Fava et  al. (1988)  ∗ X  ∗  ∗  ∗ ∗ (anx, no 
meds)
 ∗  ∗ X 7
Uvn ä s -Moeberg 
et  al. (1990)
 ∗ X X X  ∗ (anx) X X X 2
Reavely et  al. (1997)  ∗ X  ∗  ∗ X X  ∗  ∗ 5
Gro ë r (2005) X X  ∗ X X  ∗  ∗ X 3
Barry et  al. (2014)  ∗ X  ∗  ∗  ∗ ∗ (anx, stress)  ∗  ∗ X 7
 Case deﬁ nition adequate: description of PRL levels in high PRL group and how levels were measured from at least one source (medical records, etc.). 
 Representativeness of cases: either random sample from complete sampling frame, or consecutive cases. 
 Selection of controls: for the purposes of this meta-analysis, a star is given for a patient control rather than community control. 
 Deﬁ nition of controls: PRL levels measured in controls to assess their levels. 
 Comparability of both groups: give a star for any of the following: anxiety, life stress, psychiatric medication and pain. 
 Ascertainment of PRL levels: method of assay described for high PRL and patient controls. 
 Same ascertainment method for all groups: method of assay is similar in high PRL and patient controls. 
could be analysed using a fi xed-eff ects model. Th e eff ect size was 
measured as the standard mean diff erence, calculated using Hedges ’ 
 g . Like Cohen ’ s  d , a Hedges ’  g of 0.2 can be considered a small diff er-
ence; 0.5, a moderate diff erence; and 0.8 or more, a large diff erence 
between groups. Note that these eff ect size values indicate statistical 
eff ect size rather than clinical eff ect size. 
 Results 
 Studies of PRL and aggression, hostility or anger ( n    1065) were 
retrieved. Of these, 632 were duplicates, and of the remaining 433, 
a further 426 studies did not meet the inclusion criteria, leaving a 
total of 7 studies. One article (Barry et  al. 2014) was unpublished at 
the time but met the inclusion criteria, so was included. Eight stud-
ies with a total of 576 participants (242 women with high PRL, 207 
patient controls and 127 healthy controls) qualifi ed for review accord-
ing to the inclusion criteria. Th e patient control groups (as opposed 
to healthy control groups) in these studies consisted of women with 
a variety of conditions (e.g., galactorrhoea, menstrual dysfunction, 
infertility, pituitary abnormalities, micro-adenoma, uraemic women 
on dialysis and caesarean section) as well as women in the immediate 
post-partum period being visited in their homes by researchers, and 
women attending a family practice. Not all of them were hospitalised 
patients or had an illness (e.g., the post-partum group), but all were 
under some type of medical supervision so the term  ‘ patient ’ was 
applied to all, albeit somewhat loosely. 
 Regarding raw data from studies, Moss et  al. (1990) did not 
report means and SDs in a table, but Figure 1 of their article clearly 
depicts this information. Regarding duplication of previous pub-
lished fi ndings: although fi ndings from the patient control group 
of Mastrogiacomo et  al. (1982) were original and unpublished, 
two of the groups (high PRL and healthy controls) duplicated data 
published by Fava et  al. (1981). Th us a comparison of the latter 
two groups was excluded from the present meta-analysis in order 
to avoid duplication of analyses. 
 Table I shows the characteristics of the included studies. 
 Table II shows the methodological quality of the included 
studies, based on adapted NOS criteria. Th ere was generally good 
agreement between the raters regarding NOS scoring, and any 
scoring not agreed upon was discussed and resolved. 
 Main outcomes 
 Figures 1, 2 and 3 show forest plots and test statistics for the 
comparisons. Based on heterogeneity scores, outcome variables 
were meta-analysed using random-eff ects models. Table III 
summarises the results of the meta-analyses. 
 Table III shows that there were non-signifi cantly higher hos-
tility levels in the women with high PRL compared with those 
in patient controls ( Z    1.45,  p    0.15; Hedges ’ g    0.38; 95% 
CI:    0.13 – 0.89). Th ere was signifi cantly higher hostility in the 
high PRL group compared with that in healthy control women 
( Z    1.94,  p    0.05; Hedges ’ g    0.72; 95% CI:    0.01 – 1.45), and 
signifi cantly higher hostility in patient controls compared with 
that in healthy controls ( Z    1.94,  p    0.05; Hedges ’ g    0.47; 95% 
CI: 0.00 – 0.94). Th ere was considerable heterogeneity in the fi nd-
ings of these studies, with I 2 values ranging from 57% to 86%. Th e 
J O
bs
te
t G
yn
ae
co
l D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ity
 C
ol
le
ge
 L
on
do
n 
on
 0
6/
11
/1
5
Fo
r p
er
so
na
l u
se
 o
nl
y.
  Prolactin and hostility in women: A meta-analysis 5
 Table III. Results of the meta-analyses for the comparison among the three groups (high PRL group, patient controls and healthy controls). 
Analysis
Number of 
studies
Hedges ’  g 
(95% CI) Z  (P) Chi ²  (P) I ² 
Hostility in high PRL compared with  patient controls 7 0.38 (0.13 – 0.89) 1.45 ( P    0.15) 32.15 ( P    0.0001) 81%
Hostility in high PRL compared with  healthy controls 5 0.72 (0.01 – 1.45) 1.94 ( P    0.05) 28.82 ( P    0.00001) 86%
Hostility in  patient controls compared with  healthy  controls 5 0.47 (0.00 – 0.94) 1.94 ( P    0.05) 9.28 ( P    0.05) 57%
 Notes: random-eﬀ ects model used for all three comparisons due to high heterogeneity. 
confi dence intervals crossed zero in two of the three subgroup 
analyses. 
 Tables IV and V show the mean (SD) PRL and hostility scores 
in the groups. 
 Figure 4a shows the funnel plot for the studies comparing hos-
tility in women with high PRL compared with patient controls, 
and Figure 4b shows the funnel plot for the studies comparing 
hostility in women with high PRL compared with that in healthy 
controls. Both Figure 4a and b show asymmetric funnel plots, 
with the smaller studies from the 1980s (cluster of studies at lower 
right of graphs) showing the largest eff ect sizes, whereas the larger 
studies from the 1990s onwards (clustered in upper middle/left ) 
show more conservative fi ndings (smaller Hedges ’  g ). However, 
the clustering is weaker in 4(a), and perhaps not much regarding 
publication bias can be concluded from these funnel plots given 
the considerable heterogeneity in the fi ndings (Terrin et  al. 2003). 
Th e funnel plot for the comparison between patient controls and 
healthy controls is almost identical to that in Figure 4b. It can be 
interpreted in the same way as Figure 4b, and is not shown here in 
order to conserve space. 
 Table IV. Mean and SD hostility levels in the three groups. 
High PRL group Patient controls Healthy controls
Study Scale Mean SD N Mean SD N Mean SD N
Fava et  al. (1981) KSQ 8.8  b 4.6 10 3.7  b 1.9 10 2.5  b 1.9 10
Mastrogiacomo et  al. (1982) d KSQ 8.8  b 4.6 10 7.8  b 6.6 10 2.5  b 1.9 10
Kellner et  al. (1984) KSQ 10.6  b 4.1 14 4.6 b 4.4 29 4.8  b 3.8 29
Fava et  al. (1988) KSQ 7.6  b 6.0 10 6.7 b 4.3 9 2.2  b 1.5 10
Uvn ä s -Moberg et  al. (1990) KSP 10.0  e 19.5 66       10.5  e 16.1 49
Reavely et  al. (1997) SCL-90 60.7 b 11.1 65 54.9 b 11.1 26       
Gro ë r (2005) POMS 7.0 7.8 101 9.9 9.6 93 8.6 6.9 29
Barry et  al. (2014) AQ 18.2  b 6.7 32 19.8  b 9.3 30       
 AQ    Aggression Questionnaire. Scores. 
 KSQ    Kellner Symptom Questionnaire. Based on the above four studies, the mean (SD) norm    3.1 (2.5), and upper limit of normal 
(mean    2SD)    8.1. 
 KSP    Karolinska Scales of Personality. 
 POMS    Proﬁ le of Mood States. 
 SCL-90    Symptoms Checklist. 
 a Below normal range. 
 b Within normal range. 
 c Above normal range. 
 d Comparison between high PRL group and controls omitted from analysis because it duplicates that of Fava et  al. (1981). 
 e No normative data available for KSP. 
 Discussion 
 Th is meta-analysis assessed studies that compared levels of hos-
tility in women with diff erent levels of PRL. It was found that 
women with high PRL levels report more hostility than women 
with normal PRL levels. However, the apparent eff ect of PRL on 
hostility was reduced almost by half when patient controls were 
used as the comparator instead of healthy controls. In statistical 
terms, the Hedges ’  g was reduced from a moderate-to-large eff ect 
size (Hedges ’  g    0.72) to a moderate-to-small eff ect size (Hedges ’ 
 g    0.38) when controlling for patient status. Th us, roughly half of 
the hostility seen in the high PRL groups can be accounted for by 
the fact that participants are women with health issues rather than 
women who are healthy. Th e remaining eff ect size not explained 
by patient status (a Hedges ’  g of 0.34) may be attributable to PRL, 
or perhaps to a combination of PRL and other unknown factors. 
However, the fact that the confi dence intervals crossed zero in 
both of these subgroup analyses and the substantial heterogeneity 
in the fi ndings indicates that confi dence in the validity of these 
fi ndings should be tempered with caution. On the other hand, the 
fi nding of signifi cantly higher hostility in the patient control group 
 Figure 2. Forest plot of women ’ s hostility levels in the ﬁ ve studies of patients with high PRL compared with healthy controls. 
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 Table V. Mean and SD observed in PRL levels in the groups based on high versus low PRL levels. Units of PRL are 
in mIU/L. 
High PRL Patient controls Healthy controls
Study Mean SD N Mean SD N Mean SD N
Fava et  al. (1981) d    636 c 10    318 b 10 Not given 10
Mastrogiacomo et  al. (1982)    636 c 10 Not given 10 Not given 10
Kellner et  al. (1984) 3180 c 267 14 Not given 272.19 b 129.21 26
Fava et  al. (1988)    1060 c 10 527.5 c/b 9 Not given 10
Uvn ä s -Moberg et  al. (1990) Not given 49       Not given 66
Reavely et  al. (1997)    500 c Not given       
Gro ë r (2005) Not given       Not given
Barry et  al. (2014) 430.52 b 309.16 33 181.54 b 40.54 33       
 Note: conversions for PRL: ng/mL ∗ 21.2    mIU/L. (mIU/ml    mU/L    IU/L). 
 a Below normal range. 
 b Within normal range (102 – 496 mIU/L). 
 c Above normal range. 
 d Group C data not presented. 
 
 Figure 4 . Figure a shows the funnel plot for the studies comparing hostility in women with high PRL compared with patient controls, and Figure b shows 
the funnel plot for the studies comparing hostility in women with high PRL compared with that in healthy controls. 
 Figure 3. Forest plot of women ’ s hostility levels in the ﬁ ve studies of patient controls compared with healthy controls. 
compared with that in the non-patient control group (a Hedges ’ 
 g of 0.47) supports the suggestion that patient status explains at 
least a small-to-moderate (a Hedges ’  g of between 0.34 and 0.47) 
amount of the hostility seen in this meta-analysis. Although there 
was a substantial amount of heterogeneity (I 2     57%), the confi -
dence intervals did not cross zero, thus lending some statistical 
validity to the fi nding of this subgroup analysis. 
 Sometimes heterogeneity can be accounted for by diff erences 
in the methodology employed in the studies, and the heterogene-
ity seen in the fi ndings of the present study may be an example 
of this. In general, the methodological quality of the included 
studies was acceptable (a median NOS score of fi ve out of nine). 
One study (Uvn ä s-Mobcrg et  al. 1990) scored only two NOS stars, 
mainly because there were no patient controls and the healthy 
controls from a population norm. More importantly, an inspec-
tion of the characteristics of the eight studies highlights several 
ways in which they diff ered from one another. Th ese diff erences 
were seen in fi ve areas: (1) studies varied in the range of PRL lev-
els included in their comparisons; (2) half of the studies used the 
same measure of hostility (the Kellner Symptom Questionnaire 
[KSQ]), but the others used various other measures of hostility; 
(3) half of the studies used exactly the same assay method, but the 
other studies used slightly diff erent assays; (4) half of the stud-
ies had small sample sizes ( N    50); and (5) the characteristics of 
the women in the high PRL groups varied across studies. Closer 
inspection, in the following paragraphs, of the details of these dif-
ferences will allow some sense of the degree to which these diff er-
ences may infl uence how the fi ndings can be interpreted. 
 Studies varied in the range of PRL levels used in their compari-
sons, and varied in how these levels were identifi ed. It is possible 
that the eff ect of PRL on hostility is only seen when the levels are 
above the norm, yet not all studies included women with PRL 
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levels verifi ably above the norm. Th is could explain why some 
studies, which did not assess abnormally high PRL, did not fi nd a 
relationship between PRL and hostility. Furthermore, most stud-
ies included at least one group in which PRL levels are inferred 
rather than measured. For example, Table V shows that, for the 
high PRL group, two studies did not provide any information on 
the PRL levels (Uvn ä s-Mobcrg et  al. 1990; Gro ë r 2005). PRL lev-
els were not measured in three of the six patient control groups, 
and were not measured in fi ve of the six studies that used healthy 
controls, but were simply presumed to be normal. Also, in one 
study only a minority of the high PRL group had levels above the 
normal range (Barry et  al. 2014). Th e uncertainty introduced by 
this disparity in defi nition of the groups may have contributed to 
the heterogeneity in the fi ndings, though contrary to this sugges-
tion, the removal of the Barry et  al. ’ data in fact slightly increases 
the I 2 value. Apart from the issue of heterogeneity in the present 
meta-analysis, accurately measuring and verifying all of the par-
ticipants ’ PRL levels increases the clinical and scientifi c value of 
a study. Nevertheless, despite the lack of uniformity across these 
studies, they still off er valuable insights. Th e studies of high PRL 
due to medical conditions (Kellner et  al. 1984; Fava et  al. 1981; 
Fava et  al. 1988) are of importance to our understanding of the 
psychopathology of PRL, and the studies of PRL values within 
the normal range (Barry et  al. 2014) or in post-partum women 
(Gro ë r 2005; Uvn ä s-Mobcrg et  al. 1990; Mastrogiacomo et  al. 
1982) are of importance to our understanding of the normal psy-
chobiology of PRL. Future studies need to measure PRL values in 
all participants and allocate them to their corresponding groups. 
Furthermore, future research relating PRL to hostility in women 
while hospital patients compared to when they are healthy again 
would be of value as this would further elucidate the impact of 
patient status on the relationship between these variables. 
 Diff erent types of hostility questionnaire were used; four of 
the studies were consistent in the way they measured hostility, all 
using the KSQ (Kellner et  al. 1984; Mastrogiacomo et  al. 1982; 
Fava et  al. 1981; Fava et  al. 1988). Although the items in the KSQ 
are not dissimilar to items from other hostility questionnaires, it 
may be that this measure is particularly sensitive to the relation-
ship between PRL and hostility. Table V shows that the scores 
were within the known norms for all groups, whichever question-
naire was used (apart from the questionnaire used in one study 
for which a norm is not known (Gro ë r 2005)). Future studies of 
PRL and hostility should consider using the KSQ because it has 
proved to yield consistent fi ndings in this fi eld. 
 Ideally, every study would use the same type of assay for PRL. 
Some consistency was evident in the included studies, in that 
three of the studies (Kellner et  al. 1984; Mastrogiacomo et  al. 1982; 
Fava et  al. 1981; Fava et  al. 1988) used the same assay method 
(a radioimmunoassay [RIA] kit from Biodata, Italy). (One of 
the four studies from this group of authors, [Kellner et  al. 1984] 
did not state the assay used). Th e other studies used assays from 
other manufacturers, but it is unlikely that diff erences in the assay 
manufacturer or method will have contributed to the heterogene-
ity seen in the meta-analysis. Nevertheless, future studies are best 
advised to use the gold standard assay method. 
 Four studies that found the largest eff ect had small samples, 
that is, sample sizes below 50 (Fava et  al. 1981; Fava et  al. 1988; 
Mastrogiacomo et  al. 1982; Kellner et  al. 1984), and the four stud-
ies that found weak or no eff ects had sample sizes over 50 (Reav-
ley et  al. 1997; Gro ë r 2005; Uvn ä s-Mobcrg et  al. 1990). Th is might 
suggest that the apparent eff ect of PRL on hostility may in part be 
due to  ‘ small studies eff ects ’, and this would imply ungeneralisable 
fi ndings due to selection bias. However, the small studies were rel-
atively heterogeneous within their methodology and fi ndings; we 
might conclude that it would be valid to generalise their fi ndings 
to populations of women similar to those participating in those 
studies. Nonetheless, future studies should be guided by a formal 
sample size calculation and, as a general rule, recruit sample sizes 
of fi ft y at a minimum. Also, a future meta-analysis on this topic 
will be improved by an increased overall sample size. 
 Characteristics of the women in the high PRL groups varied 
across studies. It is noteworthy that the meta-analysis found that 
the diff erence in hostility levels in the three groups (high PRL, 
patient controls and healthy controls) is explained to some degree 
by whether the participants were under some kind of medical 
care or whether they were healthy. Table I shows that the charac-
teristics of the participants in the high PRL groups in the diff er-
ent studies vary by more than just PRL; most women in the high 
PRL groups had medical conditions, whereas two of the high PRL 
groups were of healthy post-partum women (Gro ë r 2005; Uvn ä s-
Mobcrg et  al. 1990). Indeed, a potential confounder of this study 
is that the control groups contained patients with conditions that 
might refl ect abnormalities in the pituitary – gonadal axis. Table I 
shows that, for example, control groups contained women with 
polycystic ovary syndrome, normoprolactinaemic pituitary dis-
ease and subfertility. Although each of these control groups can 
be justifi ed to some extent, the heterogeneity of conditions is not 
ideal in comparative studies. It is notable that the eff ect of PRL 
on hostility was generally seen most clearly in former rather than 
the latter type of group. In fact, the removal of the two studies of 
post-partum women from the comparison of high PRL to healthy 
controls improves the I 2 value from 86% to 0%, which narrows 
down the source of heterogeneity considerably, at least for the 
comparison of high PRL patients to healthy controls. On the other 
hand, removing the post-partum studies from the comparison of 
high PRL with patient controls and patient controls with healthy 
controls changes the I 2 value, but only modestly, from 81% to 76% 
and increases from 57% to 69%, respectively. Th e role of patient 
status in the relationship between PRL and hostility is particularly 
interesting, given the relationship between stress and PRL: stress 
induces PRL release (in animal models) and subsequently dimin-
ishes the stress response (Donner et  al. 2007; Torner et  al. 2004). 
It is, therefore, essential that future research adequately control 
for the impact of stress, particularly the stress related to patient 
status. 
 Future studies might also consider measuring neuroticism in 
addition to hostility, as scores on the two measures may be cor-
related (Felsten 1996). A relationship between hostility and PRL 
may also be found between neuroticism and PRL, suggesting that 
susceptibility to stress may be the underlying cause of a relation-
ship among PRL, hostility and neuroticism. 
 Any one of fi ve factors described above may have increased 
the heterogeneity, but their combination probably makes hetero-
geneity diffi  cult to avoid. However, it appears that one source of 
heterogeneity comes from the inclusion of the post-partum stud-
ies, at least for the comparison of high PRL to healthy controls, 
indicating that these studies may best be considered separately 
from studies of patients with medical conditions. In any case, 
some degree of heterogeneity is oft en seen in meta-analyses, and 
does not usually invalidate fi ndings regarding the main outcomes 
of interest. Th us, the fi ndings regarding the impact of PRL and 
patient status on hostility should be accepted, but with appropriate 
caveats regarding the type of patient population being assessed. 
 A potential limitation of this meta-analysis is that some of the 
included studies did not control for age or disease type. However, 
levels of PRL are relatively stable in women during their repro-
ductive years, and because none of the studies that reported age 
compared premenopausal women with post-menopausal women, 
it remains uncertain whether age was a confounding variable in 
those studies. Also, not all of the studies controlled for disease 
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type, that is, some studies did not compare identical disease types 
in high and low PRL groups, meaning that we cannot be sure if 
the fi ndings in these studies were related to diff erences in disease 
type rather than PRL. In general, the studies would have been 
improved by using an anxiety measure as a covariate to measure 
changes in PRL related to the stress of having a disease. 
 It is interesting to consider how the fi ndings might relate to the 
everyday clinical care of patients. Th e fi ndings from the compari-
son of patients with normal PRL to healthy controls might lead 
one to the conclusion that people who are under medical care may 
be more hostile than healthy people. It is known that pain, stress 
and medication may increase PRL levels (Torre and Falorni 2007; 
Biondi and Picardi 1999; Del Pozo and Brownell 1979). It is also 
known that the type of pain experienced by a patient infl uences 
how much these negative feelings are felt and expressed (Pilowsky 
and Spence 1976). Research by Folkman  & Lazarus (Folkman and 
Lazarus 1980) suggests that hostility and aggression are char-
acteristics of a confrontive coping style . Confrontive coping is 
described by Guthrie and Nayak (Guthrie and Nayak 2012) as one 
of the coping styles used by people in reaction to their physical 
illness. Hospitalised patients using this method of coping might 
present as being aggressive in help-seeking behaviour and hostile 
in relation to health professionals. Perhaps, it might be useful for 
such a patient to learn more acceptable coping strategies or relax-
ation training. From the point of view of everyday patient care, it 
may be preferable to treat hostility at a psychological level rather 
than a hormonal level. 
 Although one in four people with physical illness go on to 
develop a mental illness due to the stress of the physical illness 
(Guthrie and Nayak 2012), there is relatively little research into 
how the stress of having a medical condition, or being in medi-
cal care, contributes to a patient ’ s feelings of hostility. Future 
studies might explore this important issue further because it has 
a bearing on patient care, the doctor – patient relationship and 
the working environment of all those in contact with distressed 
patients. We might infer that because in many cases the source of 
a patient ’ s hostility is related to their physical discomfort rather 
than dissatisfaction with their care, it is probably important for 
health professionals to not blame patients for hostility or to not 
take hostility from patients personally. 
 In conclusion, this meta-analysis suggests that PRL may be 
associated with a female patient ’ s level of hostility. It also appears 
that the various stressors that are part of being under medical care 
may increase PRL and hostility in patients. Further high-quality, 
well-controlled research is required in order to identify defi ni-
tively the precise magnitude of the eff ect of PRL on hostility. 
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